188 related articles for article (PubMed ID: 23429468)
21. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
22. Medical management of variceal hemorrhage.
Cat TB; Liu-DeRyke X
Crit Care Nurs Clin North Am; 2010 Sep; 22(3):381-93. PubMed ID: 20691388
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with cirrhosis awaiting liver transplantation.
Cárdenas A; Ginès P
Gut; 2011 Mar; 60(3):412-21. PubMed ID: 21193458
[TBL] [Abstract][Full Text] [Related]
24. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
25. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
26. [Practice guidance for the use of terlipressin for liver cirrhosis-related complications (2021)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):859-865. PubMed ID: 36207942
[TBL] [Abstract][Full Text] [Related]
27. [Complications of liver cirrhosis].
Appenrodt B; Trebicka J; Sauerbruch T
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1601-4. PubMed ID: 21809252
[No Abstract] [Full Text] [Related]
28. Portal hypertension.
Garcia-Tsao G
Curr Opin Gastroenterol; 2006 May; 22(3):254-62. PubMed ID: 16550040
[TBL] [Abstract][Full Text] [Related]
29. Critically Ill Patients with End-Stage Liver Disease.
Crager S
Emerg Med Clin North Am; 2019 Aug; 37(3):511-527. PubMed ID: 31262418
[TBL] [Abstract][Full Text] [Related]
30. Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
Sharpton SR; Oh TG; Madamba E; Wang C; Yu RT; Atkins AR; Huan T; Downes M; Evans RM; Loomba R
Aliment Pharmacol Ther; 2022 Nov; 56(10):1475-1485. PubMed ID: 36164267
[TBL] [Abstract][Full Text] [Related]
31. [Medical therapy of complications in liver cirrhosis].
Grünhage F; Heller J; Appenrodt B; Schmitz V; Sauerbruch T
Internist (Berl); 2007 Dec; 48(12):1349-57. PubMed ID: 17992496
[TBL] [Abstract][Full Text] [Related]
32. Hepatic encephalopathy: how to test and treat.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2014 May; 30(3):265-71. PubMed ID: 24717765
[TBL] [Abstract][Full Text] [Related]
33. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
34. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.
Sorrentino P; Castaldo G; Tarantino L; Bracigliano A; Perrella A; Perrella O; Fiorentino F; Vecchione R; D' Angelo S
J Gastroenterol Hepatol; 2012 Apr; 27(4):813-22. PubMed ID: 22142548
[TBL] [Abstract][Full Text] [Related]
35. [Surgical approach to posthepatitic cirrhotic patient today].
Meriggi F; Forni E
G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
[TBL] [Abstract][Full Text] [Related]
36. Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding.
Fortune BE; Jackson J; Leonard J; Trotter JF
Expert Opin Pharmacother; 2009 Oct; 10(14):2337-42. PubMed ID: 19708854
[TBL] [Abstract][Full Text] [Related]
37. Complications of cirrhosis.
Dong MH; Saab S
Dis Mon; 2008 Jul; 54(7):445-56. PubMed ID: 18570914
[No Abstract] [Full Text] [Related]
38. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological therapy for the treatment of esophageal varices.
Lowe RC
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):215-23. PubMed ID: 16557191
[TBL] [Abstract][Full Text] [Related]
40. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
